Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.

Chinese Pharmaceutical Companies Dominating Global Research & Development Landscape Of Bispecific ADC Market Says Kuick ...

It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...

In this video interview, Ron Lanton, partner, Lanton Law, discusses how a potential increase in drug costs could affect the ...

The new review of Alzheimer’s disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs.

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...

In this video interview, Ron Lanton, partner, Lanton Law, talks FDA layoffs and their impact on inspections and clinical ...

Paradromics completes first human BCI implant, setting stage for clinical trials targeting severe motor impairment.

There’s been a leap in potential new medicines being tested in clinical trials for Alzheimer’s, according to a new annual ...